uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

QURE uniQure NV

Post-Mkt 07-08 18:22:10 EDT

43.49

+2.08

+5.02%

盘后43.25

-0.24-0.55%

17:58 EDT

High43.59	Low40.75	Vol1.90M
Open41.42	D1 Closing41.41	Amplitude6.86%
Mkt Cap2.96B	Tradable Cap2.65B	Total Shares68.01M
T/O81.85M	T/O Rate3.13%	Tradable Shares60.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"QURE","market":"US","secType":"STK","nameCN":"uniQure NV","latestPrice":43.49,"timestamp":1783540800000,"preClose":41.41,"halted":0,"volume":1904794,"hourTrading":{"tag":"盘后","latestPrice":43.25,"preClose":43.49,"latestTime":"17:58 EDT","volume":11523,"amount":501125.440881,"timestamp":1783547893369,"change":-0.24,"changeRate":-0.005519,"amplitude":0.011497},"delay":0,"changeRate":0.050229413185221096,"floatShares":60879399,"shares":68011000,"eps":-3.486371,"marketStatus":"Post-Mkt","change":2.08,"latestTime":"07-08 18:22:10 EDT","open":41.42,"high":43.59,"low":40.75,"amount":81854129.695036,"amplitude":0.068582,"askPrice":43.75,"askSize":125,"bidPrice":43,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-3.486371,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1783555200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1391576400000,"exchange":"NASDAQ","adjPreClose":41.41,"preHourTrading":{"tag":"盘前","latestPrice":41.5,"preClose":41.41,"latestTime":"09:28 EDT","volume":1436,"amount":59079.247132,"timestamp":1783517280101,"change":0.09,"changeRate":0.002173,"amplitude":0.027047},"postHourTrading":{"tag":"盘后","latestPrice":43.25,"preClose":43.49,"latestTime":"17:58 EDT","volume":11523,"amount":501125.440881,"timestamp":1783547893369,"change":-0.24,"changeRate":-0.005519,"amplitude":0.011497},"volumeRatio":1.025433,"optionData":{"bulkOrders":[{"symbol":"QURE","call":true,"expireDate":1792123200000,"strike":"55.0","timestamp":1783534645929,"price":5.43,"volume":1262,"amount":685266,"type":"+"}]},"impliedVol":1.0284,"impliedVolPercentile":0.3147},"requestUrl":"/m/hq/s/QURE","defaultTab":"news","newsList":[{"id":"2649930462","title":"Uniqure CEO Matthew Kapusta Disposes of USD 956,528 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930462","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930462?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:48","pubTimestamp":1783457296,"startTime":"0","endTime":"0","summary":"uniQure CEO Matthew Kapusta disposes of USD 956,528 in common sharesuniQure CEO and Managing Director Matthew C. Kapusta exercised stock options for 21,082 ordinary shares at $19.39 on July 2, 2026.He","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL1Z1KyF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Uniqure CEO Matthew Kapusta Disposes of USD 956,528 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","QURE","LU0109394709.USD","LU0889565916.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648633055","title":"Uniqure Director Jack Kaye Disposes of Ordinary Shares Worth $954,615.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2648633055","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648633055?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:56","pubTimestamp":1783025760,"startTime":"0","endTime":"0","summary":"uniQure director Jack Kaye disposes of ordinary shares worth $954,615.3uniQure director Jack Kaye cut his ordinary-share stake to 25,996 shares in transactions dated June 30, 2026.Sold 21,167 ordinary","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL7Vj9xM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Uniqure Director Jack Kaye Disposes of Ordinary Shares Worth $954,615.3","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE","LU0320765992.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124287037","title":"Movement Alert｜uniQure Falls 8.11% in Regular Trading, Dilution Pressure From Upsized $259 Million Offering Continues to Weigh on Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1124287037","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124287037?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:26","pubTimestamp":1783009581,"startTime":"0","endTime":"0","summary":"On July 3, uniQure N.V. declined 8.11% in regular trading, trading at $41.4/share with turnover of approximately $60.42 million. The stock has now fallen well below the $45.50 offering price from its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647761378","title":"Uniqure is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2647761378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647761378?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:17","pubTimestamp":1782728220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QURE/analyst-ratings(END) Dow Jones NewswiresJune 29, 2026 06:17 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0109394709.USD","LU0889565916.HKD","QURE","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378517","title":"uniQure price target raised to $80 from $50 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378517?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:00","pubTimestamp":1782727216,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on uniQure (QURE) to $80 from $50 and keeps a Buy rating on the shares. The firm believes the June 1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/uniqure-price-target-raised-to-80-from-50-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/uniqure-price-target-raised-to-80-from-50-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4139","LU0109394709.USD","QURE","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646788398","title":"Uniqure CEO Matthew Kapusta Sells 35,412 Shares for $1.77 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2646788398","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646788398?lang=en_us&edition=fundamental","pubTime":"2026-06-27 05:16","pubTimestamp":1782508567,"startTime":"0","endTime":"0","summary":"uniQure CEO Matthew Kapusta sells 35,412 shares for $1.77 millionuniQure CEO and Managing Director Matthew C. Kapusta cut his ordinary share stake to 519,227 shares in transactions on June 24-25.Dispo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL3wNck4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Uniqure CEO Matthew Kapusta Sells 35,412 Shares for $1.77 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0320765992.SGD","QURE","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646324783","title":"uniQure (QURE) Is Up 6.1% After Equity Raise And FDA Backing For Accelerated HD Filing - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2646324783","media":"Simply Wall St.","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646324783?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:15","pubTimestamp":1782458141,"startTime":"0","endTime":"0","summary":"Over the past week, uniQure N.V. completed an upsized US$225,000,003 follow-on equity offering of 4,945,055 ordinary shares at US$45.50 each, shortly after reporting initial AMT-260 epilepsy data and confirming FDA support for using three-year AMT-130 results as the basis for an accelerated approval filing in Huntington’s disease.\nAn interesting angle is how uniQure is pairing early but encouraging central nervous system gene therapy readouts with an expanded share capital base to fund...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/uniqure-qure-is-up-61-after-equity-raise-and-fda-backing-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/uniqure-qure-is-up-61-after-equity-raise-and-fda-backing-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","IE00BZ1G4Q59.USD","LU2756315664.SGD","LU0823411888.USD","LU0868494708.USD","LU0238689110.USD","LU1674673428.USD","BK4566","BK4550","LU0234572021.USD","HD","LU0320765646.SGD","LU0354030511.USD","LU1496350502.SGD","LU1551013425.SGD","BK4533","IE00BKVL7J92.USD","LU2461242641.AUD","BK4139","LU2361045086.USD","LU1035775433.USD","LU0689472784.USD","LU1093756168.USD","BK4215","SG9999001440.SGD","BK4083","LU1674673691.USD","LABU","BK4534","LU1236620834.HKD","LU1778281490.HKD","IE00BSNM7G36.USD","LU0820562030.AUD","LU1093756325.SGD","BK4567","LU0098860793.USD","LU2361044949.HKD","EQR","LU0354030438.USD","LU0943347566.SGD","QURE","LU0823434583.USD","LU1989772923.USD","LU1069344957.HKD","LU0823434740.USD","LU0079474960.USD","LU1551013342.USD","LU0942090050.USD","BK4504","LU2756315318.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646386432","title":"UniQure Closes $259 Million Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2646386432","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646386432?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:44","pubTimestamp":1782420276,"startTime":"0","endTime":"0","summary":"UniQure  closed a public offering of almost 5.69 million common shares at $45.50 each for gross proceeds of about $259 million.The offering included 741,758 shares issued upon the full exercise of an overallotment option by the underwriters, the company said Thursday in a statement.UniQure plans to use the proceeds to advance AMT-130, develop other pipeline programs and support general corporate needs.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU0889565916.HKD","LU0109394709.USD","QURE","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646438592","title":"Uniqure Prices Upsized Follow-on Offering of 5,686,813 Shares at $45.5 Each, Raising $259 Million Gross","url":"https://stock-news.laohu8.com/highlight/detail?id=2646438592","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646438592?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:10","pubTimestamp":1782418217,"startTime":"0","endTime":"0","summary":"uniQure prices upsized follow-on offering of 5,686,813 shares at $45.5 each, raising $259 million grossuniQure closed an upsized underwritten follow-on offering of 5,686,813 ordinary shares at USD 45.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL7SQjCx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","LU0109394709.USD","BK4585","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","BK4139","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD","LU2210150020.SGD","BK4588","IE00BKPKM429.USD","LU0314104364.USD","LU0889565916.HKD","LU0320765992.SGD","NDAQ","QURE","LU2095319765.USD","SG9999014021.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646443368","title":"Analysts Are Bullish on These Healthcare Stocks: Ionis Pharmaceuticals (IONS), uniQure (QURE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646443368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646443368?lang=en_us&edition=fundamental","pubTime":"2026-06-25 06:30","pubTimestamp":1782340219,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ionis Pharmaceuticals (IONS) and uniQure (QURE) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ionis-pharmaceuticals-ions-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ionis-pharmaceuticals-ions-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0889565916.HKD","LU0109394709.USD","QURE","LU0320765992.SGD","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645245898","title":"uniQure Prices $225 Million Ordinary Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2645245898","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645245898?lang=en_us&edition=fundamental","pubTime":"2026-06-24 15:58","pubTimestamp":1782287905,"startTime":"0","endTime":"0","summary":"uniQure (QURE) has priced its upsized secondary public common share offering to about 4.9 million ordinary shares at $45.50 per share for gross proceeds of about $225 million, the company said Tuesday","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","QURE","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645586873","title":"uniQure prices upsized public offering at $45.5 per share, raising $225 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2645586873","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645586873?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:14","pubTimestamp":1782263649,"startTime":"0","endTime":"0","summary":"uniQure priced an upsized underwritten public offering of 4,945,055 ordinary shares at USD 45.5 each.Gross proceeds expected at about USD 225 million, before underwriting discounts, commissions, fees.Underwriters hold a 30-day option to buy up to 741,758 additional ordinary shares at the offering price.Closing expected on or about June 25, 2026, subject to customary conditions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL1G82jg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE","LU0314104364.USD","SG9999014021.USD","LU0320765992.SGD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","SG9999014013.SGD","NDAQ","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4588","LU2095319765.USD","BK4585","SG9999014039.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU0889565916.HKD","LU0109394709.USD","LU2210150020.SGD","BK4112","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191034373","title":"Movement Alert｜uniQure Rises 8.4% in Regular Trading, $150 Million Public Offering Signals Commitment to BLA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=1191034373","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191034373?lang=en_us&edition=fundamental","pubTime":"2026-06-24 02:47","pubTimestamp":1782240472,"startTime":"0","endTime":"0","summary":"On June 24, uniQure rose 8.4% in regular trading, trading at approximately $48.00 per share with turnover of $93.05 million. The advance extends the upward momentum following a major FDA regulatory...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645830640","title":"BUZZ-U.S. STOCKS ON THE MOVE-Boundless Bio, Galectin, UniQure","url":"https://stock-news.laohu8.com/highlight/detail?id=2645830640","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645830640?lang=en_us&edition=fundamental","pubTime":"2026-06-23 23:46","pubTimestamp":1782229560,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Boundless Bio, Galectin, UniQureWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nL6N42V0ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4139","BOLD","LU0109394709.USD","LU0320765992.SGD","GALT","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645837755","title":"uniQure rises 7.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645837755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645837755?lang=en_us&edition=fundamental","pubTime":"2026-06-23 23:04","pubTimestamp":1782227090,"startTime":"0","endTime":"0","summary":"uniQure (QURE) is up 7.6%, or $3.35 to $47.74. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/uniqure-rises-7-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/uniqure-rises-7-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0320765992.SGD","LU0889565916.HKD","QURE","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645023832","title":"Positive Report for uniQure (QURE) from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2645023832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645023832?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:35","pubTimestamp":1782225352,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Eliana Merle from Barclays upgraded uniQure to a Buy, with a price target of $65.00. Merle covers the Healthcare se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-uniqure-qure-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-uniqure-qure-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0320765992.SGD","BK4581","LABU","XBI","BK4588","XLV","LU0889565916.HKD","LU0109394709.USD","BK4585","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645077748","title":"UniQure Announces Planned $150 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2645077748","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645077748?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:16","pubTimestamp":1782159370,"startTime":"0","endTime":"0","summary":"UniQure  said Monday it has started a $150 million underwritten public offering of its shares and, in lieu of shares to some investors, pre-funded warrants to buy shares, subject to market conditions.The company said it plans to give underwriters a 30-day option to buy up to an additional $22.5 million of its shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QURE","LU0889565916.HKD","BK4139","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645077992","title":"uniQure launches USD 150 million follow-on share offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2645077992","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645077992?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:01","pubTimestamp":1782158481,"startTime":"0","endTime":"0","summary":"uniQure launched an underwritten public offering targeting USD 150 million of ordinary shares or pre-funded warrants.All securities will be sold by the company; terms remain subject to market conditions.Underwriters hold a 30-day option to buy up to an additional USD 22.5 million of ordinary shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL1mNNyG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4585","BK4112","SG9999014013.SGD","LU2210149790.SGD","LU0320765992.SGD","NDAQ","BK4207","BK4139","IE00BN0W2T93.GBP","LU2210150020.SGD","SF","MNSH","IE00BN0W2W23.USD","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4127","SG9999014039.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","IE00B64PRP62.GBP","BK4588","IE00BGHQF748.EUR","LU0109394709.USD","QURE","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024878","title":"uniQure director Jack Kaye sells 5,295 shares for $225,211.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024878","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024878?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:54","pubTimestamp":1782129292,"startTime":"0","endTime":"0","summary":"uniQure director Jack Kaye sold 5,295 ordinary shares on June 17, 2026 at a weighted average price of $42.57.The sale followed the exercise of stock options for 5,295 ordinary shares at $31.71 on the same day.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. uniQure NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL8Ymr5m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"uniQure director Jack Kaye sells 5,295 shares for $225,211.35","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0320765992.SGD","LU0889565916.HKD","QURE","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645010617","title":"Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645010617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645010617?lang=en_us&edition=fundamental","pubTime":"2026-06-22 10:30","pubTimestamp":1782095405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ClearPoint Neuro (CLPT) and uniQure (QURE) with bull...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-clearpoint-neuro-clpt-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-clearpoint-neuro-clpt-uniqure-qure-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QURE","BK4082","CLPT","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.uniqure.com","stockEarnings":[{"period":"1week","weight":-0.101},{"period":"1month","weight":0.5656},{"period":"3month","weight":1.606},{"period":"6month","weight":0.7888},{"period":"1year","weight":1.8938},{"period":"ytd","weight":0.7305}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0138},{"period":"3month","weight":0.1061},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.2047},{"period":"ytd","weight":0.0965}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.009035},{"month":2,"riseRate":0.5,"avgChangeRate":0.032875},{"month":3,"riseRate":0.307692,"avgChangeRate":-0.046417},{"month":4,"riseRate":0.461538,"avgChangeRate":0.033828},{"month":5,"riseRate":0.692308,"avgChangeRate":0.072742},{"month":6,"riseRate":0.461538,"avgChangeRate":0.038554},{"month":7,"riseRate":0.230769,"avgChangeRate":0.02275},{"month":8,"riseRate":0.5,"avgChangeRate":0.005984},{"month":9,"riseRate":0.25,"avgChangeRate":0.122705},{"month":10,"riseRate":0.5,"avgChangeRate":0.060394},{"month":11,"riseRate":0.75,"avgChangeRate":0.0616},{"month":12,"riseRate":0.25,"avgChangeRate":0.125134}],"exchange":"NASDAQ","name":"uniQure NV","nameEN":"uniQure NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest uniQure NV(QURE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"uniQure NV,QURE,uniQure NV股票,uniQure NV股票老虎,uniQure NV股票老虎国际,uniQure NV行情,uniQure NV股票行情,uniQure NV股价,uniQure NV股市,uniQure NV股票价格,uniQure NV股票交易,uniQure NV股票购买,uniQure NV股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"uniQure NV(QURE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest uniQure NV(QURE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}